Q4 2019 CellaVision AB Earnings Call Transcript
()-&
Good morning, everybody. Zlatko Rihter here from Lund. I'm here together with Maria Morin who is Head of the Corporate Communications and IR here at CellaVision; and also Magnus Blixt who is the CFO. So -- and he, myself -- and I, Zlatko Rihter.
So basically, what I will do today is I'll go through the presentation as I usually do. Just a quick comment initially, as you know that we closed the transaction of RAL Diagnostics, October 1. And that also means that all of their sales and all of their numbers are included in the Q4 report. So it's a little bit of a new CellaVision that emerges now. And of course, we'll try to comment as much as possible on that also.
So my suggestion is that we move to Slide #3. And even if we have a new world up there with RAL included, still the mission we have from CellaVision's perspective as corporation is still the same, we strongly believe that by replacing traditional microscopes, preferably or initially now in hematology labs, we create value, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
